Carlo Patrono - Curriculum vitae#

• 1962 B.S, Arts, Liceo Classico Nazareno; Rome, Italy
• 1968 M.D.Cum Laude Catholic University School of Medicine, Rome, Italy
• 1969-1971 Postdoctoral Fellow Medicine Bronx Veterans Administration, Hospital and Mount Sinai, School of Medicine, New York, U.S.A.

• 1972-1982 Assistant Professor, Department of Pharmacology, Catholic University School of Medicine, Rome
• 1983-1985 Associate Professor, Department of Pharmacology Catholic University School of Medicine, Rome
• 1984-1985 Lecturer in Medicine, Mount Sinai School of Medicine, New York, USA
• 1985-1986 Visiting Professor, Department of Pharmacology, King's College, London, Departments of Medicine (Cardiovascular Unit) and Clinical Pharmacology, Royal Postgraduate Medical School London, U.K.
• 1991-2001 Professor of Pharmacology University of Chieti, "G. D'Annunzio" School of Medicine
• 1996-1997 Visiting Professor of University of Pennsylvania Pharmacology School of Medicine, Philadelphia, USA
• 2001- Director, MIUR Center of “G. D’Annunzio” University Excellence on Aging Foundation, Chieti
• 2001-2006 Professor of Pharmacology University of Rome “La Sapienza” 2nd School of Medicine
• 2007- Professor and Chair of Pharmacology Catholic University School of Medicine, Rome

• Member of the Italian Society of Pharmacology, 1968-
• Founding Member, Association for Patient-Oriented Research
• Member of the Council on Arteriosclerosis, Thrombosis, and Vascular Biology of the American Heart Association
• Honorary Member of the Association of American Physicians, 1991-
• Fellow of the European Society of Cardiology, 1994-
• Member of the Council on Thrombosis of the International Society and Federation of Cardiology, 1994-1996
• Chairman, Working Group "Thrombosis and Platelets" of the European Society of Cardiology, 1994-1996
• Member of the Advisory Committee of the General Clinical Research Center, University of Pennsylvania, 1996-1997
• Member of the Cardiovascular Review Committee, Commission of the European Communities, BIOMED Programme, 1997
• Fellow of the Royal College of Physicians in Ireland, 1998-
• Chairman, Task Force on Antithrombotic Agents of the European Society of Cardiology, 2000-2003 and 2009-
• External Advisor, NIH Center in Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 2000-
• Chair, International COX-2 Study Group, 2002-2005
• Fellow of the Royal College of Physicians, 2003-
• Member of Academia Europaea, 2004-
• Member of Accademia Nazionale dei Lincei, 2004-

• 1980: Alexander B. Gutman Visiting Professorship of Medicine, awarded by the Mount Sinai School of Medicine, New York
• 1981: Upjohn Award "Excellence in Pharmacology" of the Italian Society of Pharmacology
• 1982: W.N. Creasy Visiting Professorship of Clinical Pharmacology, awarded by the Burroughs Wellcome Fund
• 1985: Senior Fellowship, awarded by the British Council
• 1998: International Aspirin® Senior Award, awarded by Bayer AG
• 2007: John Vane Award of the University of London

• Co-Editor of 7 books and journal issues (see list of publications).
• Member of the Editorial Board of Clinical and Experimental Rheumatology (1982-present)
• Member of the Editorial Board of the European Journal of Clinical Pharmacology (1984-2007)
• Member of the Editorial Board of Trends in Cardiovascular Medicine (1990-1995)
• Field Editor (Cardiovascular Pharmacology) of Pharmacological Research (1999-2008)
• Member of the Editorial Board of Circulation (2000-present)
• Member of the Editorial Board of Arteriosclerosis, Thrombosis and Vascular Biology (2002-present)
• Member of the Editorial Advisory Board of Molecular Interventions, (2005-present)

1. European Commission, 6th Framework Programme, EICOSANOX “Eicosanoids and Nitric Oxide: Mediators of Cardiovascular, Cerebral & Neoplastic Diseases” 2005-2009 (Cluster Leader and Member of the Project Steering Committee)
2. “Antiplatelet Effects of a 12-hour Dosing Interval of Low-Dose Aspirin Administration in Patients with Type 2 Diabetes Mellitus and Enhanced Platelet Turnover” (2008-2010), funded by Bayer HealthCare AG (Principal Investigator)
3. “A Longitudinal Study of the Time-Course of Platelet Activation During the Development and Progression of Type 2 Diabetes Mellitus” (2009-2011), funded by Bayer HealthCare AG (Principal Investigator)
4. Innovative Medicines Initiative “Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools (SUMMIT)” (2009-2013) Co-Investigator

• Member of Consiglio Direttivo, Centro di Scienze dell’Invecchiamento, Fondazione Università “G. d’Annunzio”
• Member of the Ethics Committee, Catholic University School of Medicine, Rome
• Chair of the Drug Therapy Committee, Catholic University School of Medicine, Rome.